Hironic Calls 2026 EGM to Re-approve Director Remuneration Limit and Retirement Pay Rules

Hironic will hold an extraordinary general meeting on June 8, 2026, to re-approve director remuneration limit (Agenda 1) and executive retirement pay rule amendments (Agenda 2).
The company is a leading domestic manufacturer of HIFU-based aesthetic medical devices, having obtained 45 new global certifications in 2024-2025 and signed large-scale supply contracts in North America.
The board has consistently pursued shareholder return policies, including self-share acquisition trust agreements (Jul 30, Nov 8, Dec 11, 2024; Mar 20, 2025) and bonus share issuances (Jan 20, 2023; Jan 24, 2024).